» Articles » PMID: 39239112

Towards a Personalized Prediction, Prevention and Therapy of Insomnia: Gut Microbiota Profile Can Discriminate Between Paradoxical and Objective Insomnia in Post-menopausal Women

Abstract

Background: Insomnia persists as a prevalent sleep disorder among middle-aged and older adults, significantly impacting quality of life and increasing susceptibility to age-related diseases. It is classified into objective insomnia (O-IN) and paradoxical insomnia (P-IN), where subjective and objective sleep assessments diverge. Current treatment regimens for both patient groups yield unsatisfactory outcomes. Consequently, investigating the neurophysiological distinctions between P-IN and O-IN is imperative for devising novel precision interventions aligned with primary prediction, targeted prevention, and personalized medicine (PPPM) principles.Working hypothesis and methodology.Given the emerging influence of gut microbiota (GM) on sleep physiology via the gut-brain axis, our study focused on characterizing the GM profiles of a well-characterized cohort of 96 Italian postmenopausal women, comprising 54 insomniac patients (18 O-IN and 36 P-IN) and 42 controls, through 16S rRNA amplicon sequencing. Associations were explored with general and clinical history, sleep patterns, stress, hematobiochemical parameters, and nutritional patterns.

Results: Distinctive GM profiles were unveiled between O-IN and P-IN patients. O-IN patients exhibited prominence in the family, including and , along with , , and . Conversely, P-IN patients were mainly discriminated by , , , , and respective families, along with .

Conclusions: These findings provide valuable insights into the microbiota-mediated mechanism of O-IN versus P-IN onset. GM profiling may thus serve as a tailored stratification criterion, enabling the identification of women at risk for specific insomnia subtypes and facilitating the development of integrated microbiota-based predictive diagnostics, targeted prevention, and personalized therapies, ultimately enhancing clinical effectiveness.

Supplementary Information: The online version contains supplementary material available at 10.1007/s13167-024-00369-1.

Citing Articles

Association of prebiotic/probiotic intake with MASLD: evidence from NHANES and randomized controlled trials in the context of prediction, prevention, and a personalized medicine framework.

Wang S, Zhang R, Guo P, Yang H, Liu Y, Zhu H EPMA J. 2025; 16(1):183-197.

PMID: 39991098 PMC: 11842653. DOI: 10.1007/s13167-025-00398-4.


Better objective sleep quality is associated with higher gut microbiota richness in older adults.

Wijaya M, Fang J, Liu G, Yeh Y, Chen N, Lin C Geroscience. 2025; .

PMID: 39888583 DOI: 10.1007/s11357-025-01524-w.

References
1.
Smith R, Easson C, Lyle S, Kapoor R, Donnelly C, Davidson E . Gut microbiome diversity is associated with sleep physiology in humans. PLoS One. 2019; 14(10):e0222394. PMC: 6779243. DOI: 10.1371/journal.pone.0222394. View

2.
Tavella T, Rampelli S, Guidarelli G, Bazzocchi A, Gasperini C, Pujos-Guillot E . Elevated gut microbiome abundance of is associated with reduced visceral adipose tissue and healthier metabolic profile in Italian elderly. Gut Microbes. 2021; 13(1):1-19. PMC: 7889099. DOI: 10.1080/19490976.2021.1880221. View

3.
Szentirmai E, Millican N, Massie A, Kapas L . Butyrate, a metabolite of intestinal bacteria, enhances sleep. Sci Rep. 2019; 9(1):7035. PMC: 6504874. DOI: 10.1038/s41598-019-43502-1. View

4.
Brewster G, Riegel B, Gehrman P . Insomnia in the Older Adult. Sleep Med Clin. 2022; 17(2):233-239. DOI: 10.1016/j.jsmc.2022.03.004. View

5.
Rezaie L, Fobian A, McCall W, Khazaie H . Paradoxical insomnia and subjective-objective sleep discrepancy: A review. Sleep Med Rev. 2018; 40:196-202. DOI: 10.1016/j.smrv.2018.01.002. View